4D Molecular Therapeutics, Inc. ( NASDAQ:FDMT – Get Free Report )’s share price traded down 8.4% on Thursday . The stock traded as low as $13.96 and last traded at $13.7460. 626,080 shares traded hands during trading, a decline of 25% from the average daily volume of 833,405 shares. The stock had previously closed at $15.00.
Analyst Upgrades and Downgrades A number of research firms recently commented on FDMT. Weiss Ratings reiterated a “sell (d-)” rating on shares of 4D Molecular Therapeutics in a report on Friday, July 17th. B. Riley Financial restated a “buy” rating on shares of 4D Molecular Therapeutics in a research note on Monday, August 17th. Chardan Capital raised shares of 4D Molecular Therapeutics to a “strong-buy” rating in a research report on Tuesday, July 28th. The Goldman Sachs Group reaffirmed a “buy” rating and set a $32.00 target price on shares of 4D Molecular Therapeutics in a report on Thursday, August 13th. Finally, HC Wainwright reiterated a “buy” rating and issued a $36.00 price target on shares of 4D Molecular Therapeutics in a research note on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, one h...